Non‐alcoholic fatty liver disease (NAFLD) is a common disease that is concomitant with obesity, resulting in increased mortality. To date, the efficiency of NAFLD treatment still needs to be improved. Therefore, we aimed to evaluate the effect of Lactobacillus mali APS1, which was isolated from sugary kefir, on hepatic steatosis in rats fed a high‐fat diet (HFD).

中文翻译：

---

含糖牛乳牛乳杆菌APS1通过调节SIRT-1 / Nrf-2和肠道菌群改善了肝脂肪变性

非酒精性脂肪性肝病（NAFLD）是肥胖症的常见疾病，导致死亡率增加。迄今为止，NAFLD治疗的效率仍然需要提高。因此，我们旨在评估从含糖开菲尔分离出的马来乳酸杆菌APS1对高脂饮食（HFD）大鼠肝脂肪变性的影响。